Biotechnology Stocks I Performance Guide: MoonLake Immunotherapeutics (MLTX)
MLTX has no dividends
Table and Chart of MLTX Performance
See what a $1,000 investment in MLTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MLTX Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $10.40 |
| End Date | Dec-01-2023 |
| End Price | $46.10 |
| # Prices | 38 |
| Min Date | Jun-30-2022 |
| Min Price | $5.25 |
| Max Date | Jul-31-2023 |
| Max Price | $60.81 |
| Total Return | 343.27% |
| Annualized Return | 60.03% |
| Current Value of $1,000 Purchase | $4,433 |
| Number Returns | 703 |
| Average Return | 151.95% |
| Number Profitable Returns | 444 |
| Percent Profitable Returns | 63.16% |
| Number Unprofitable Returns | 259 |
| Percent Unprofitable Returns | 36.84% |
| Profitable to Unprofitable Returns Ratio | 1.71 |
| MLTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,763,557,000 | Price to Sales |
| Earnings per Share | $-1.0600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.5 |
| PRICE DATA | |
| 52 Week High | $63.4 |
| 52 Week Low | $9.08 |
| Analyst Target Price | $69.5 |
| 50-Day Moving Average | $49.76 |
| 200-Day Moving Average | $39.77 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.184% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MLTX Compare Returns with S&P 500
MLTX Trendline Chart